Explore cutting-edge research on glioblastoma treatment strategies in this 51-minute lecture presented by Dr. Thomas Hillen from the University of Alberta as part of the Fields Institute's Graduate Course in Mathematical Oncology. Delve into the complex mechanisms of immune evasion in glioblastoma and learn about innovative approaches targeting tumour-associated macrophages to enhance therapeutic outcomes. Gain insights into the intersection of mathematical modeling and cancer immunotherapy, specifically focusing on strategies to overcome the immunosuppressive tumor microenvironment in brain cancer treatment.
Overcoming Immune Evasion in Glioblastoma by Targeting Tumour-Associated Macrophages
Overview
Syllabus
Overcoming immune evasion in glioblastoma by targeting tumour-associated macrophages
Taught by
Fields Institute
Related Courses
-
Targeting Macrophages to Improve Glioblastoma Treatment Outcomes
-
Optimal Control of Combination Immunotherapy for a Virtual Murine Cohort in a Glioblastoma-Immune Dynamics Model
-
Understanding Immune Activation and Evasion in the Tumor Microenvironment - Why Lymphocyte Relationships Matter
-
How Cancer-Associated Fibroblasts Promote T-Cell Exclusion in Human Lung Tumors: A Physical Perspective
-
Modelling the Impact of Intra-Tumour Heterogeneity on Radiotherapy Outcomes
-
What Can Viral Dynamics Teach Us About Modeling Immunotherapies?
